Qube Research & Technologies (QRT)
ASND icon

Qube Research & Technologies (QRT)’s Ascendis Pharma A/S ASND Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52,753
Closed -$12.1M – 3458
2026
Q1 		$12.1M Sell
52,753
-140,711
-73% -$31.5M 0.01% 1169
2025
Q4 		$41.3M Sell
193,464
-96,708
-33% -$20M 0.04% 586
2025
Q3 		$57.7M Buy
290,172
+89,128
+44% +$16.6M 0.06% 409
2025
Q2 		$34.7M Buy
201,044
+91,412
+83% +$14.9M 0.04% 611
2025
Q1 		$17.1M Buy
109,632
+96,887
+760% +$13.8M 0.02% 828
2024
Q4 		$1.75M Buy
12,745
+7,194
+130% +$946K ﹤0.01% 1937
2024
Q3 		$829K Sell
5,551
-49,197
-90% -$6.64M ﹤0.01% 2097
2024
Q2 		$7.47M Buy
+54,748
New +$7.45M 0.01% 1071
2021
Q2 		– Sell
-9,016
Closed -$1.16M – 2247
2021
Q1 		$1.16M Sell
9,016
-7,953
-47% -$1.21M 0.02% 792
2020
Q4 		$2.83M Buy
+16,969
New +$2.81M 0.04% 481
2020
Q3 		– Sell
-21,227
Closed -$3.14M – 1666
2020
Q2 		$3.14M Buy
+21,227
New +$2.91M 0.05% 506

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ASND Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 52,753 shares — an estimated $12.1M sold.

Qube Research & Technologies (QRT) first reported a position in ASND in Q2 2020 and held it in 11 quarters. The position peaked at $57.7M in Q3 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 52,753 Ascendis Pharma A/S shares in Q2 2026, an estimated $12.1M.
  • Qube Research & Technologies (QRT) first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Ascendis Pharma A/S position peaked at $57.7M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.